EIF4G2

Eukaryotic translation initiation factor 4 gamma 2 · P78344 · EIF4G2 on Sugi Atlas →

0 patent compounds predicted against EIF4G2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to EIF4G2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Tumor Gene Expression in Women With Ovarian Cancer PHASE4COMPLETED
Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit PHASE2/PHASE3WITHDRAWN
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer PHASE1/PHASE2COMPLETED
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. PHASE1/PHASE2RECRUITING
Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Quantification of GADD34 Expression in RA nanCOMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
MEHMO Natural History and Biomarkers nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Exploring the Genetics of Neuropathic Pain nanRECRUITING
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Precision Medicine in Anesthesia nanWITHDRAWN
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans nanUNKNOWN
Muscle Regrowth During Physical Rehabilitation and Amino Acid Supplementation nanCOMPLETED
The Sapienza University Mortality and Morbidity Events Rate (SUMMER) Study in Diabetes nanCOMPLETED
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a EIF4G2 binder may also engage these)

ProteinNameSimilarity
Q5R7J9 1.000 Q5R7J9 →
P79398 1.000 P79398 →
Q95L46 1.000 Q95L46 →
Q62448 1.000 Q62448 →
Q86T65 0.987 Q86T65 →
O43150 0.987 O43150 →
Q9ERA6 0.987 Q9ERA6 →
Q32NW2 0.987 Q32NW2 →
KDM5B Lysine-specific demethylase 5B 0.986 landscape →
PPP2R5D Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform 0.986 landscape →
Q8BX57 0.986 Q8BX57 →
Q7SIG6 0.986 Q7SIG6 →
P32744 0.986 P32744 →
A4UMC5 0.986 A4UMC5 →
Q28653 0.986 Q28653 →
DHX29 ATP-dependent RNA helicase DHX29 0.986 landscape →
Q5R5K8 0.985 Q5R5K8 →
A1XD95 0.985 A1XD95 →
A1XD94 0.985 A1XD94 →
Q5U2Y6 0.985 Q5U2Y6 →
P25799 0.985 P25799 →
Q91857 0.985 Q91857 →
Q9U1H9 0.985 Q9U1H9 →
O01763 0.984 O01763 →
Q7Z3E5 0.984 Q7Z3E5 →
NFKB1 Nuclear factor NF-kappa-B p105 subunit 0.984 landscape →
A1XD97 0.984 A1XD97 →
Q95RG8 0.984 Q95RG8 →
O54774 0.984 O54774 →
Q29RR5 0.984 Q29RR5 →